The 5th National Urologic Oncology Update

Last Modified: February 10, 2003

Conference Dates: February 28 - March 1, 2003
Conference Location: Newport Beach, California

Sponsoring Group: Imedex, Inc.

Conference Web Page URL:

Topics Covered: Diagnosis and Management of Bladder Cancer, Adrenal Tumors, Renal Cell Carcinoma, Testis Cancer, Prostate Cancer, Urology in the 21st Century: Challenges and Opportunities

Conference Objectives: Objectives After successfully completing this educational program, participants should be able to: Recommend the most appropriate techniques for the diagnosis, treatment, and monitoring of superficial bladder cancer, Advise their patients with muscle invasive or metastatic bladder cancer on their treatment options, Discuss the merits of urinary diversion and orthotopic bladder replacement techniques, Discuss the role of observation, surgery, systemic therapy, and combined modality therapy in the management of renal cell carcinoma, Advise patients with upper tract transitional cell carcinoma on their management options, Advise their patients with testicular or adrenal malignancies on their treatment options, Comment on the merits of screening for prostate cancer, Recommend the most appropriate management options for patients with clinically localized, recurrent or advanced prostate cancer, Evaluate methods for the reduction of post-prostat! ectomy incontinence and impotence, Discuss the merits of laparoscopic vs. open surgery for selected urologic surgical procedures.

Who Should Attend: This program is intended for urologists, oncologists, radiation therapists, and other practitioners involved in the diagnosis and management of urologic cancers. No specific knowledge or skills other than a basic training in one of the above-mentioned disciplines is required for successful participation in the program.

Registration Information: Online:, Telephone: 770-751-7332, Fax: 770-751-7334, email:

Conference Fees: Physicians: $499, $50 group discount. Nurses/Fellows/Residents: $349.

Continuing Education: Yes

Miscellany: 12.5 hours, category 1. Conference Chairman: Andrew C. Novick, M.D., The Cleveland Clinic, Cleveland, Ohio


My Cancer Experience
by Bob Riter
October 06, 2015

Related News

ASCO Issues Recommendations for Promoting Tobacco Control

Jul 30, 2013

Improved education, support for tobacco control policies, more research recommended

Preoperative Breast MRI Use Increased From 2003 to 2012

Oct 10, 2015

Eight-fold increase during 10-year period; MRI use linked to more ancillary investigations

Guidance Updated for Sentinel Node Biopsy in Breast Cancer

Mar 27, 2014

ASCO updates its 2005 guideline for use of sentinel node biopsy in early breast cancer